Open | $1.080 |
Close | $1.050 |
Volume / Avg. | 1.146M / 1.278M |
Day Range | 1.010 - 1.120 |
52 Wk Range | 0.499 - 1.914 |
Market Cap | $46.522M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | % |
Days to Cover | 2.89 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of SELLAS Life Sciences Gr (NASDAQ: SLS) through any online brokerage.
Other companies in SELLAS Life Sciences Gr’s space includes: NKGen Biotech (NASDAQ:NKGN), Cellectar Biosciences (NASDAQ:CLRB), Bolt Biotherapeutics (NASDAQ:BOLT), Elicio Therapeutics (NASDAQ:ELTX) and vTv Therapeutics (NASDAQ:VTVT).
The latest price target for SELLAS Life Sciences Gr (NASDAQ: SLS) was reported by Cantor Fitzgerald on Wednesday, November 22, 2023. The analyst firm set a price target for 3.00 expecting SLS to rise to within 12 months (a possible 180.43% upside). 2 analyst firms have reported ratings in the last year.
The stock price for SELLAS Life Sciences Gr (NASDAQ: SLS) is $1.0698 last updated March 18, 2024 at 7:53 PM EDT.
There are no upcoming dividends for SELLAS Life Sciences Gr.
SELLAS Life Sciences Gr’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for SELLAS Life Sciences Gr.
SELLAS Life Sciences Gr is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.